The predictive value of microRNA-126 in relation to first line treatment with capecitabine and oxaliplatin in patients with metastatic colorectal cancer
<p>Abstract</p> <p>Background</p> <p>MicroRNA-126 is the only microRNA (miRNA) known to be endothelial cell-specific influencing angiogenesis in several ways. The aim of the present study was to analyse the possible predictive value of miRNA-126 in relation to first lin...
Main Authors: | Hansen Torben, Sørensen Flemming, Lindebjerg Jan, Jakobsen Anders |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-03-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1471-2407/12/83 |
Similar Items
-
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker study
by: Reem D. Mahmood, et al.
Published: (2021-04-01) -
The Role of MicroRNAs in Colorectal Cancer
by: Sang Wook Kim
Published: (2017-04-01) -
Angioregulatory microRNAs in Colorectal Cancer
by: Mohammad Hasan Soheilifar, et al.
Published: (2019-12-01) -
Differentially expressed microRNAs in colorectal cancer metastasis
by: Mohammed Abba, et al.
Published: (2015-12-01) -
OXALIPLATIN/5-FLUOROURACIL/LEUCOVORIN IN THE TREATMENT OF PATIENTS WITH METASTATIC COLORECTAL CANCER
by: Deyan N. Davidov
Published: (2013-12-01)